Ethopropazine
Back to searchMolecule Structure
Scientific Name
Ethopropazine
Description of the Drug
Profenamine is an antidyskinetic phenothiazine used to treat the symptoms of Parkinson’s disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00392
http://www.drugbank.ca/drugs/DB00392
Brand Name(s)
Not Available
Company Owner(s)
Parke Davis Div Warner Lambert Co
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscarinic acetylcholine receptor M1 | SINGLE PROTEIN | ANTAGONIST | CHEMBL216 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34045 | |
| PharmGKB | PA449531 | |
| Human Metabolome Database | HMDB0014536 | |
| DrugBank | DB00392 | |
| PubChem: Thomson Pharma | 14923459 | |
| PubChem | 3290 | |
| Mcule | MCULE-1873220615 | |
| LINCS | LSM-1342 | |
| Nikkaji | J2.060E | |
| BindingDB | 8958 | |
| EPA CompTox Dashboard | DTXSID2023018 | |
| DrugCentral | 1086 | |
| Brenda | 2999 | 47224 |
| Guide to Pharmacology | 7181 | |
| rxnorm | ETHOPROPAZINE HYDROCHLORIDE | PROFENAMINE |
| ChEBI | 313639 |
